| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | Director, 10%+ Owner | Common Stock | 4,235,403 | $90,425,854 | $21.35 | 12 Jan 2026 | Indirect |
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 4,425,784 | $70,768,286 | $15.99 | 02 Nov 2021 | Indirect |
| Repare Therapeutics Inc. | Director | Stock Option (right to buy) | 27,200 | 08 Jun 2023 | Direct | ||
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 11,918 | 02 Jun 2022 | Direct | ||
| Aktis Oncology, Inc. | Director, 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | Director, 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | Director, 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| CHIASMA, INC | Director | Stock Option (Right to Buy) | 0 | 05 Aug 2021 | Direct | ||
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Series A Preferred Stock | 0 | 02 Nov 2021 | Indirect | ||
| Entrada Therapeutics, Inc. | Director, 10%+ Owner | Series B Preferred Stock | 0 | 02 Nov 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 12 Jan 2026 | 7 | +$4,191,660 | 4 | Director, 10%+ Owner | 14 Jan 2026, 18:20 |
| AKTS | Aktis Oncology, Inc. | 08 Jan 2026 | 0 | $0 | 3 | Director, 10%+ Owner | 08 Jan 2026, 21:03 |
| RPTX | Repare Therapeutics Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:24 |
| TRDA | Entrada Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Jun 2022, 16:11 |
| RPTX | Repare Therapeutics Inc. | 13 May 2022 | 1 | $0 | 4 | Director | 16 May 2022, 19:27 |
| TRDA | Entrada Therapeutics, Inc. | 02 Nov 2021 | 5 | +$2,000,000 | 4 | Director, 10%+ Owner | 04 Nov 2021, 17:36 |
| TRDA | Entrada Therapeutics, Inc. | 28 Oct 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 01 Nov 2021, 17:22 |
| TRDA | Entrada Therapeutics, Inc. | 28 Oct 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 28 Oct 2021, 20:44 |
| /report/000120919121050016-foley-todd-2021-08-05 | CHIASMA, INC | 05 Aug 2021 | 5 | $0 | 4 | Director | 05 Aug 2021, 17:29 |
| RPTX | Repare Therapeutics Inc. | 09 Jul 2021 | 3 | -$917,678 | 4 | Director | 13 Jul 2021, 16:22 |
| RPTX | Repare Therapeutics Inc. | 28 Jun 2021 | 3 | -$288,136 | 4 | Director | 30 Jun 2021, 17:26 |
| RPTX | Repare Therapeutics Inc. | 24 Jun 2021 | 2 | -$423,620 | 4 | Director | 28 Jun 2021, 16:08 |
| RPTX | Repare Therapeutics Inc. | 21 Jun 2021 | 5 | -$647,950 | 4 | Director | 23 Jun 2021, 17:38 |
| RPTX | Repare Therapeutics Inc. | 17 Jun 2021 | 4 | -$617,762 | 4 | Director | 21 Jun 2021, 16:08 |
| RPTX | Repare Therapeutics Inc. | 14 Jun 2021 | 2 | -$91,213 | 4 | Director | 16 Jun 2021, 17:10 |
| RPTX | Repare Therapeutics Inc. | 08 Jun 2021 | 4 | -$921,529 | 4 | Director | 10 Jun 2021, 16:05 |
| RPTX | Repare Therapeutics Inc. | 03 Jun 2021 | 6 | -$820,274 | 4 | Director | 07 Jun 2021, 18:40 |
| RPTX | Repare Therapeutics Inc. | 28 May 2021 | 4 | -$545,041 | 4 | Director | 02 Jun 2021, 17:40 |
| RPTX | Repare Therapeutics Inc. | 25 May 2021 | 6 | -$557,635 | 4 | Director | 27 May 2021, 19:55 |
| RPTX | Repare Therapeutics Inc. | 21 May 2021 | 3 | -$4,974,688 | 4 | Director | 24 May 2021, 20:13 |
| RPTX | Repare Therapeutics Inc. | 18 May 2021 | 8 | -$710,270 | 4 | Director | 20 May 2021, 19:21 |
| RPTX | Repare Therapeutics Inc. | 13 May 2021 | 1 | $0 | 4 | Director | 14 May 2021, 16:56 |